J. Mitchell Winkler, MD

Born in Little Rock, Arkansas, Dr. Winkler attended Hendrix College in Conway, where he received his B.A. in biology. He attended medical school at the University of Arkansas College of Medicine, where he also completed his internship and residency. He completed his oncology fellowship at Mayo Clinic in Rochester, Minnesota. He is board certified in internal medicine, medical oncology, hematology, and hospice and palliative medicine.


“I want patients to live as well as possible, as long as possible.”


  • Treatment of all cancer types
  • Treatment of adult blood disorders
  • National Cancer Institute (NCI) Community Oncology Research Program (NCORP) trial participant
  • Advanced symptom and side effect management
  • Collaborative, patient-centered care design
  • Compassionate, honest prognostication
  • End-of-life planning and care


  • University of Arkansas for Medical Sciences, College of Medicine, Little Rock, AR


  • University of Arkansas for Medical Sciences, Department of Internal Medicine, Little Rock, AR


  • Medical Oncology & Hematology: Mayo Clinic Divisions of Hematology and Oncology, Rochester, MN
  • Research: Mayo Clinic Division of Hematology, Rochester, MN


  • Internal Medicine
  • Medical Oncology
  • Hematology
  • Hospice & Palliative Medicine


  • Special interest in palliative care
  • Co-authored articles for various physician publications regarding blood cancers and treatments
  • Born in Little Rock, Arkansas
  • Father of two
  • Enjoys biking, movie making, poker, and history


Mitch has boundless energy and an unyielding approach to finding the most suitable solutions for each of his patients.
KEY TRAITS: Vivacious, receptive, lighthearted

  • Jerry's Blog Posts

    Men absolutely get breast cancer. It happens here in Green Bay. I’ve treated it. So it’s absolutely a thing. But men get breast cancer about 100 times LESS often than ...

    For several months in the spring of 2020, clinics and hospitals across the United States temporarily suspended routine cancer screening during the early phase of the COVID outbreak. Patients we’d ...